Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2008
06/12/2008WO2008068170A1 Hdac inhibitors
06/12/2008WO2008068159A1 Spiro-piperidine derivatives
06/12/2008WO2008068157A1 2-aminoquinolines as 5-ht(5a) receptor antagonists
06/12/2008WO2008068127A1 Thuggacin-type macrolide antibiotics and their use as antimycobacterial agents
06/12/2008WO2008068043A1 Use of epothilones in the treatment of osteoporosis and related diseases
06/12/2008WO2008068041A1 Crystalline potassium salt of lipoxin a4 analogs
06/12/2008WO2008068037A1 Cholesterylamines for the treatment and prevention of infectious diseases
06/12/2008WO2008067995A2 Means and method for raising improved immune response
06/12/2008WO2008067982A2 Use of carrageenan for treating rhinovirus infections
06/12/2008WO2008067909A2 Urea and sulfamide derivatives as tafia inhibitors
06/12/2008WO2008067892A1 Sulphamate benzothiophene derivatives
06/12/2008WO2008067874A1 Substituted dipyridyl-dihydropyrazolones and use thereof
06/12/2008WO2008067871A1 Substituted dihydropyrazolones for treating cardiovascular and haematological diseases
06/12/2008WO2008067863A2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt
06/12/2008WO2008067781A2 A method of purification of (s)-n-methyl-3-(1-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride (duloxetine)
06/12/2008WO2008067774A1 An antimycotic pharmaceutical composition
06/12/2008WO2008067773A1 New crystal types of febuxostat and their preparation methods
06/12/2008WO2008067756A1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
06/12/2008WO2008067752A1 A process for preparing optical pure milnacipran and its pharmaceutically accepted salts
06/12/2008WO2008067713A1 Compounds having substituted cyclopentane structure, their preparation methods and medical uses
06/12/2008WO2008067712A1 Compounds having substituted cyclopropane structure, preparation method and uses thereof
06/12/2008WO2008067711A1 Compounds having substituted 4-members ring structure and their medicine uses
06/12/2008WO2008067710A1 Substituted cyclohexane compounds, preparation methods and medicine uses thereof
06/12/2008WO2008067709A1 Substituted cyclobutane compounds, preparation methods and pharmaceutical uses thereof
06/12/2008WO2008067687A1 The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use therrof
06/12/2008WO2008067670A1 Tablets comprising entacapone and crospovidone
06/12/2008WO2008067644A1 Inhibitors of hiv replication
06/12/2008WO2008067641A1 Composition for improving blood flow in working muscles comprising l-arginine, crataegus extract and artichoke flavonoids
06/12/2008WO2008067640A1 Composition for promoting cognitive attributes
06/12/2008WO2008067639A1 Composition for promoting weight loss comprising yohimbine, evodia rutaecarpia extract and l-carnitine
06/12/2008WO2008067630A1 Method of increasing growth hormone secretion
06/12/2008WO2008067610A1 Method for reducing inflammatory responses and inflammation
06/12/2008WO2008067609A1 Method and composition for reducing reperfusion injury
06/12/2008WO2008057300A3 Trpvi antagonists and uses thereof
06/12/2008WO2008052033A3 Ibuprofen composition
06/12/2008WO2008051533A3 Benzimidazole compounds
06/12/2008WO2008051272A3 Somatostatin agonists
06/12/2008WO2008049178A8 Stable and ready-to-use oil-in-water propofol microemulsion
06/12/2008WO2008049020A3 Diclofenac gel
06/12/2008WO2008048648A3 Cb1-modulating compounds and their use
06/12/2008WO2008048560A3 Toll-like receptor agonist regulation of vegf-induced tissue responses
06/12/2008WO2008048084B1 Pharmaceutical combinations for the treatment of dyslipidemia accompanied by high blood pressure
06/12/2008WO2008048083B1 Pharmaceutical compositions for the treatment of thromboembolic diseases
06/12/2008WO2008046799A3 Preparation of granules of hydrophilic vitamins
06/12/2008WO2008046796A3 Use of c10-c14-alkane-1,2-diols in the preparation of a composition for the prophylaxis and/or treatment of dermatophyte infections
06/12/2008WO2008046581A3 Substituted tetrahydropyrrolopyrazine compounds and use thereof in medicaments
06/12/2008WO2008045534A3 Novel curcumin and tetrahydrocurcumin derivatives
06/12/2008WO2008045410A3 Alcohol free formulation of argatroban
06/12/2008WO2008045393A3 Imidazo- and triazolo-pyridine compounds and methods of use therof
06/12/2008WO2008045391A3 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
06/12/2008WO2008042970A3 Chitosan-coated calcium sulfate based medicament delivery system
06/12/2008WO2008042688A3 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
06/12/2008WO2008040799A3 Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release
06/12/2008WO2008039473A3 Alcohol free formulation of argatroban
06/12/2008WO2008038175A3 Dithiolopyrrolones compounds and their therapeutic applications
06/12/2008WO2008037888A3 Tetracyclic compounds, process for the preparation thereof pharmaceutical compositions comprising the same and use thereof as dopaminergic receptor ligands
06/12/2008WO2008037416A3 Use of theogallin for the treatment of mental concentration disorders, depression and dementia
06/12/2008WO2008036809A3 Methods and materials for reducing risk of cold and/or flu
06/12/2008WO2008036747A3 Composition and method for immunomodulation
06/12/2008WO2008035305A3 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia
06/12/2008WO2008034859A8 Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
06/12/2008WO2008031556A3 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions
06/12/2008WO2008028081A3 Sperm cell separation methods and compositions containing aptamers or nucleic acid sequences for use therein
06/12/2008WO2008027648A3 Methods and compositions for treating pathologies associated with bdnf signaling
06/12/2008WO2008020596A3 Treating or preventing cancers over-expressing reg4 or kiaa0101
06/12/2008WO2008018909A3 Laser energy calibration based on optical measurement
06/12/2008WO2008017361A3 2-(heterocyclylbenzyl)pyridazinone derivatives
06/12/2008WO2008016768A8 Phytoestrogenic formulations and uses thereof
06/12/2008WO2008015517A3 Ep2 agonists
06/12/2008WO2008015190A8 Treatment and prevention of excessive scarring
06/12/2008WO2008014888A3 Imino-imidazo-pyridine derivatives having antithrombotic activity
06/12/2008WO2008014232A3 Pharmaceutical formulations for the treatment of alzheimer's disease
06/12/2008WO2008012690A3 Use of 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, for the preparation of a medicament intended for the treatment of degenerative joint diseases
06/12/2008WO2008011179A3 Omega-3 fatty acids for use in treating resistant hypertension
06/12/2008WO2008011178A3 Compositions comprising omega-3 fatty acids, and their use in treating peripheral artery disease and intermittent claudication
06/12/2008WO2008000483A3 Phenol derivatives for the treatment of respiratory diseases
06/12/2008WO2007148208A3 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands
06/12/2008WO2007144152A3 Extended step-down estrogen regimen
06/12/2008WO2007143523A3 Fused, tricyclic sulfonamide inhibitors of gamma secretase
06/12/2008WO2007143486A3 Treatment of hot flashes using muscarinic receptor antagonists such as oxybutynin
06/12/2008WO2007134868A3 3,5-dihydroxy-2,4-cyclohexadienones and their derivatives, dietary compositions and fortified food containing them and their uses
06/12/2008WO2007132344A3 Controlled release compositions of an antidepressant agent
06/12/2008WO2007132338A3 IL-1α IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS
06/12/2008WO2007132292A3 Therapy for alzheimer's disease
06/12/2008WO2007128802A3 Use of flibanserin for the treatment of post-menopausal sexual desire disorders
06/12/2008WO2007128537A3 Pharmaceutical preparation based on myrtucommulone a for the selective tumour and cancer therapy
06/12/2008WO2007127913A3 Reducing risk of type 2 diabetes (t2d)
06/12/2008WO2007119109A3 Processes for preparing tegaserod maleate and pharmaceutical compositions containing it
06/12/2008WO2007118323A8 Isoxazole derivatives as calcium channel blockers
06/12/2008WO2007115931A8 Thiazolyldihydrocyclopentapyrazoles for use as pi3-kinase inhibitors
06/12/2008WO2007112433A3 Compositions for promoting hair growth
06/12/2008WO2007111994A3 Compounds and methods for treatment of disorders associated with er stress
06/12/2008WO2007111945A3 Method for management of diarrhea
06/12/2008WO2007110237A3 Amide derivatives and their application for the treatment of g protein related diseases
06/12/2008WO2007106550A3 Methods and compositions for deterring abuse of orally administered pharmaceutical products
06/12/2008WO2007098273A3 Novel crystalline forms of armodafinil and preparation thereof
06/12/2008WO2007097991A3 Methods and kits for dosing of antiviral agents
06/12/2008WO2007089548A3 Compounds and methods for modulating protein trafficking
06/12/2008WO2007087429A3 Phenyl and pyridyl compounds for inflammation and immune-related uses
06/12/2008WO2007081597A3 Peri condensed tricyclic compounds useful as antibacterial agents
1 ... 3223 3224 3225 3226 3227 3228 3229 3230 3231 3232 3233 3234 3235 3236 3237 3238 3239 3240 3241 3242 3243 ... 7860